Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Phosphatidylinositol 3-kinase Pathway
100%
Resistance to Aromatase Inhibitor
100%
PI3 Kinase Signaling
100%
Breast Cancer Cell Lines
50%
Estrogen Receptor-positive Breast Cancer
50%
Hormone Receptor-positive Breast Cancer
50%
Pathway Signaling
50%
Treatment Response
25%
Phosphoinositide 3-kinase (PI3K)
25%
Effective Treatment
25%
Acquired Resistance
25%
PIK3CA
25%
Poor Outcome
25%
Estrogen Receptor
25%
Cell Survival
25%
Catalytic Subunit
25%
Breast Cancer Subtypes
25%
Endocrine Therapy
25%
Treatment Modalities
25%
Synthetic Lethality
25%
Endocrine Resistance
25%
Pathway Inhibitors
25%
Genetic Abnormalities
25%
Estrogen Deprivation
25%
Phosphatidylinositol 3-kinase Signaling
25%
Endocrine-resistant Breast Cancer
25%
Luminal B Subtype
25%
Medicine and Dentistry
Phosphoinositide 3-Kinase
100%
Aromatase Inhibitor
100%
Breast Cancer
42%
Hormone Therapy
28%
Cell Signaling Pathway
28%
Breast Cancer Cell Line
28%
Hormone Receptor
28%
Estrogen Receptor Positive Breast Cancer
28%
Treatment Response
14%
Cell Survival
14%
Estrogen Receptor
14%
Enzyme Active Site
14%
Lethality
14%
Kinase Signaling
14%
Therapy Resistance
14%
Treatment Modality
14%
Effective Treatment
14%
Biochemistry, Genetics and Molecular Biology
Phosphoinositide 3-Kinase
100%
Aromatase Inhibitor
100%
Estrogen Receptor
42%
Cancer Cell
28%
Hormone Receptor
28%
Enzyme Active Site
14%
Genetics
14%
Cell Survival
14%
Synthetic Lethality
14%